Alessandro Pezzini Selected Research

Blood Vessel Dissection

5/2023	Recanalization Therapies for Large Vessel Occlusion Due to Cervical Artery Dissection: A Cohort Study of the EVA-TRISP Collaboration.
1/2022	Antithrombotic therapy in the postacute phase of cervical artery dissection: the Italian Project on Stroke in Young Adults Cervical Artery Dissection.
12/2011	Mutations in TGFBR2 gene cause spontaneous cervical artery dissection.
12/2007	Migraine mediates the influence of C677T MTHFR genotypes on ischemic stroke risk with a stroke-subtype effect.
9/2007	Antiplatelets versus anticoagulation in cervical artery dissection.
3/2006	Diagnostic flow chart for targeted detection of alpha1-antitrypsin deficiency.
10/2002	Hyperhomocysteinemia: a potential risk factor for cervical artery dissection following chiropractic manipulation of the cervical spine.
3/2002	Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke.
1/2002	Alpha-1-antitrypsin deficiency-associated cervical artery dissection: report of three cases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alessandro Pezzini Research Topics

Disease

40	Stroke (Strokes) 12/2023 - 03/2002
30	Ischemic Stroke 12/2023 - 03/2002
12	Atrial Fibrillation 02/2024 - 01/2012
9	Blood Vessel Dissection 05/2023 - 01/2002
9	Hemorrhage 01/2022 - 08/2015
7	Cerebral Hemorrhage 02/2024 - 11/2016
6	COVID-19 07/2022 - 01/2020
5	Hypertension (High Blood Pressure) 10/2021 - 02/2004
5	Migraine Disorders (Migraine) 01/2021 - 04/2006
4	Brain Ischemia (Cerebral Ischemia) 09/2021 - 01/2007
4	Myocardial Infarction 03/2015 - 01/2004
3	Leukocytosis (Pleocytosis) 10/2022 - 01/2020
3	Infections 10/2021 - 01/2014
3	Hematoma 01/2020 - 02/2014
2	Thrombosis (Thrombus) 02/2024 - 06/2017
2	Hypercholesterolemia 02/2024 - 01/2020
2	Type 2 Diabetes Mellitus (MODY) 10/2023 - 01/2020
2	Pulmonary Embolism 01/2020 - 09/2012
2	Fibromuscular Dysplasia 06/2019 - 01/2014
2	Infarction (Infarctions) 05/2019 - 03/2012
2	Embolic Stroke 01/2019 - 08/2015
2	Migraine with Aura (Familial Hemiplegic Migraine) 01/2019 - 04/2014
2	Leukoaraiosis 01/2019 - 03/2017
2	Embolism (Embolus) 06/2017 - 01/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2016 - 08/2004
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2008 - 01/2007
2	Hyperhomocysteinemia 01/2007 - 10/2002
1	Venous Thrombosis (Deep-Vein Thrombosis) 06/2024
1	Coronary Artery Disease (Coronary Atherosclerosis) 02/2024
1	Hemophilia A (Haemophilia) 05/2023
1	Cerebral Small Vessel Diseases 01/2023
1	Calcinosis 01/2023
1	Sepsis (Septicemia) 01/2023
1	Aortic Dissection 11/2022
1	Fever (Fevers) 05/2021
1	Venous Thromboembolism 01/2020
1	Encephalitis (Encephalitis, Rasmussen) 01/2020
1	Wounds and Injuries (Trauma) 06/2019
1	Disease Susceptibility (Diathesis) 03/2019
1	Epilepsy (Aura) 01/2019
1	Pain (Aches) 01/2019

Drug/Important Bio-Agent (IBA)

18	AnticoagulantsIBA 01/2023 - 09/2007
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2024 - 06/2009
6	Vitamin K FDA Link 12/2023 - 09/2015
6	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2011
5	HomocysteineIBA 01/2008 - 03/2002
4	Apolipoproteins E (ApoE)IBA 12/2023 - 02/2004
4	ORALIT (ORS)IBA 10/2021 - 02/2004
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022 - 01/2016
3	Tissue Plasminogen Activator (Alteplase)FDA Link 09/2021 - 01/2012
3	ApolipoproteinsIBA 01/2019 - 02/2004
3	CholesterolIBA 01/2016 - 06/2009
3	Prothrombin (Factor II)IBA 03/2015 - 03/2005
3	Folic Acid (Vitamin M)FDA LinkGeneric 02/2011 - 01/2004
2	Heparin (Liquaemin)FDA LinkGeneric 12/2023 - 09/2012
2	LipidsIBA 10/2023 - 06/2009
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2023 - 01/2016
2	RNA (Ribonucleic Acid)IBA 01/2021 - 06/2017
2	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 04/2014
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2019 - 09/2012
2	Factor V (Coagulation Factor V)IBA 03/2015 - 03/2005
2	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 02/2011 - 01/2007
2	Fibrinogen (Factor I)FDA Link 01/2008 - 08/2004
2	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 12/2007 - 03/2005
2	Vitamin E FDA LinkGeneric 08/2004 - 01/2004
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 06/2024
1	Complement System Proteins (Complement)IBA 12/2023
1	ElastinIBA 01/2023
1	Oral ContraceptivesIBA 01/2023
1	CollagenIBA 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2023
1	Adenosine DeaminaseIBA 01/2023
1	C-Reactive ProteinIBA 10/2022
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2022
1	Oxygen (Dioxygen)IBA 05/2021
1	Estrogens (Estrogen)FDA Link 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2020
1	SteroidsIBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	Interleukin-8 (Interleukin 8)IBA 01/2020
1	Metformin (Glucophage)FDA LinkGeneric 01/2020
1	Enoxaparin (Lovenox)FDA LinkGeneric 01/2020
1	parthenolideIBA 01/2019
1	MagnesiumIBA 01/2019
1	TabletsIBA 01/2019
1	Tryptophan (L-Tryptophan)FDA Link 01/2019
1	Warfarin (Coumadin)FDA LinkGeneric 01/2018
1	Protein CIBA 01/2018
1	ThrombomodulinIBA 01/2018
1	Endothelial Protein C ReceptorIBA 01/2018
1	activated protein C receptorIBA 01/2018
1	RivaroxabanIBA 11/2017
1	apixabanIBA 11/2017
1	Dabigatran FDA Link 11/2017

Therapy/Procedure

23	Therapeutics 12/2023 - 01/2007
9	Thrombectomy 01/2023 - 03/2017
7	Secondary Prevention 01/2022 - 05/2009
2	Thrombolytic Therapy 01/2020 - 01/2012
1	Transcutaneous Electric Nerve Stimulation (TENS) 12/2023
1	Musculoskeletal Manipulations (Manipulative Therapy) 06/2019